# Alpha-synuclein in Cerebrospinal Fluid to Differentiate Alzheimer's Disease From Lewy Body Disease.

> **NCT01876459** · NA · UNKNOWN · sponsor: **University Hospital, Strasbourg, France** · enrollment: 265 (estimated)

## Conditions studied

- "Alzheimer's Disease" and "Lewy Body Disease"

## Interventions

- **OTHER:** MRI
- **PROCEDURE:** lumbar puncture
- **BEHAVIORAL:** neuropsychological tests

## Key facts

- **NCT ID:** NCT01876459
- **Lead sponsor:** University Hospital, Strasbourg, France
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-04
- **Primary completion:** 2015-04
- **Final completion:** 2015-04
- **Target enrollment:** 265 (ESTIMATED)
- **Last updated:** 2013-06-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01876459

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01876459, "Alpha-synuclein in Cerebrospinal Fluid to Differentiate Alzheimer's Disease From Lewy Body Disease.". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01876459. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*